PTC Therapeutics (PTCT) Gets a Buy from RBC Capital
RBC Capital analyst Brian Abrahams maintained a Buy rating on PTC Therapeutics (PTCT – Research Report) yesterday and set a price target of ...
PTC Therapeutics price target lowered to $72 from $74 at JPMorgan
JPMorgan analyst Eric Joseph lowered the firm’s price target on PTC Therapeutics (PTCT) to $72 from $74 and keeps an Overweight rating on the ...